跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 31,007 条关于
“low-density lipoprotein cholesterol”
全部
31,007
临床试验
23,844
药物
457
机构
57
资讯
6,649
6个月前
FDA Approves Juxtapid for Pediatric Patients with Homozygous Familial Hypercholesterolemia
去年
Plozasiran Shows Promise in Reducing Triglycerides in Phase 3 and Extension Studies
去年
Zerlasiran Shows Promise in Phase II Trial for Elevated Lipoprotein(a)
25天前
FDA Updates Leqvio Label to Recognize LDL-C Reduction Lowers Cardiovascular Event Risk
去年
AHA Advocates for Expanded Lipoprotein Apheresis Use in High-Risk Cardiovascular Patients
去年
Jongkundang Receives FDA Clearance for Phase 1 Trial of Novel Hyperlipidemia Drug CKD-508
去年
Junshi Biosciences' Ongericimab Approved in China for Hypercholesterolemia and Mixed Dyslipidemia
去年
Plozasiran Shows Promise in Reducing Cholesterol and Triglycerides in Mixed Hyperlipidemia Patients
去年
Adjunctive PCSK9 Inhibitor Evolocumab Shows Promise in Preventing Early Neurological Deterioration in Acute Ischemic Stroke
去年
Zerlasiran Demonstrates Significant Lipoprotein(a) Reduction in Phase II Trial
第 1 页,共 665 页
上一页
下一页